Pharma Industry News

Fresenius Kabi Breaks Ground on $250-Million Facility Expansion

On Sep. 21, 2017, Fresenius Kabi, a German specialty and generic pharmaceuticals company and a subsidiary of Fresenius SE & Co. KGaA, broke ground on a $250-million expansion of its Melrose Park, IL manufacturing facility. The site, announced in August 2016, will facilitate the aseptic mOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]